Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3QZR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $51,385
Award facts
- Contract value 100% obligated
- $51,384.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $51,384.55 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on December 9, 2025, with an ultimate completion date of December 10, 2025. This firm fixed price, non-set-aside contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $1 billion and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems, fulfills this order as part of its extensive portfolio of medical product deliveries to the Defense Logistics Agency and the Defense Health Agency. The company's federal contract awards demonstrate consistent capability in supplying a wide range of pharmaceutical products through competitive, non-set-aside procurements with firm fixed pricing. Dupixent is a biologic medication used primarily for treating eczema, asthma, and other inflammatory conditions, supporting the military health system's pharmaceutical supply needs through this established prime vendor relationship.
Quick answers
Who was awarded contract SPE2DR26F3QZR?
SPE2DR26F3QZR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26F3QZR worth?
The government has obligated $51,385 on SPE2DR26F3QZR.
Is contract SPE2DR26F3QZR an order under another contract?
Yes. SPE2DR26F3QZR is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3QZR competed?
The extent of competition for SPE2DR26F3QZR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award